Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹268.05.
29 Oct: open ₹269.90, high ₹269.90, low ₹261.80
- Next results date: the board meets on 5 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,465 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,90,10349.4% delivered
Suven Life Sciences share news and announcements
803 announcements, routine notices left out, newest first. Page 3 of 17.
Jan 2024
30 Jan · Business
30 Jan · Management
30 Jan · Board meeting
30 Jan · Results
14 Jan · Legal
The exchange asked on 12 Jan 2024
3 Jan · Legal
The exchange asked on 2 Jan 2024
Nov 2023
4 Nov · Business
4 Nov · Results
Oct 2023
27 Oct · Board meeting
Aug 2023
8 Aug · Results
1 Aug · Board meeting
Jul 2023
11 Jul · Updates
11 Jul · Meeting
Jun 2023
May 2023
9 May · Business
9 May · Business
9 May · Updates
9 May · Board meeting
9 May · Results
Mar 2023
Feb 2023
9 Feb · Business
2 Feb · Business
2 Feb · Results
Jan 2023
25 Jan · Board meeting
Nov 2022
22 Nov · Related Party Transaction
16 Nov · Corporate action
Oct 2022
18 Oct · Outcome of committee meeting
12 Oct · Corporate action
12 Oct · Outcome of committee meeting
7 Oct · Board meeting
Aug 2022
Jul 2022